SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 413.19+1.1%Jan 6 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Julius Wong who wrote (177807)9/7/2021 1:03:57 AM
From: TobagoJack   of 219063
 
Let’s watch & brief

‘Recombinant protein’ - whatever that be - liquid that showed promise for both preventative as well as therapeutic efficacy across the alphabets in non-human primate studies

If good, prospective game-changer, in American English language, or killer-app in silicon valley speak

scmp.com

China / Science

Chinese Covid-19 vaccine gets UAE nod for therapeutic use trial

Approval follows earlier green light in the UAE and New Zealand for preventive use trials of YishengBio vaccine
Patients with mild to moderate Covid-19 infections will be targeted first in trial of regimen involving two shots seven days apart



In a non-human primate preclinical study, monkeys were infected with coronavirus first before being injected with what Shao called the first therapeutic Covid-19 vaccine in the country, with “promising results”.



Shao said animal serum studies showed the YishengBio vaccine could offer broad and lasting protection against coronavirus variants including Alpha, Beta, Gamma and Lambda even at day 448 post vaccination, indicating good durability of the immune response. With just a week needed to complete the regimen, the vaccine would be potentially very useful during an outbreak.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext